AGY — Allergy Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapMomentum Trap

Annual balance sheet for Allergy Therapeutics, fiscal year end - June 30th, GBP millions except per share, conversion factor applied.

	2020 June 30th	2021 June 30th	R2022 June 30th	2023 June 30th	2024 June 30th
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	37	40.3	20.5	14.8	12.9
Net Total Accounts Receivable
Net Total Receivables	5.83	4.62	5.91	5.06	6.21
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	55.2	57.9	42.4	33.5	33.5
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	20.4	19.7	20.2	23.2	23.7
Net Goodwill
Net Intangible Assets
Long Term Investments
Total Assets	86.2	88.1	72.9	66.8	64.8
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	18.2	18.2	18.1	18.6	20.5
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	42.4	39.6	35.2	64.7	61.1
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	43.8	48.5	37.8	2.07	3.71
Total Liabilities & Shareholders' Equity	86.2	88.1	72.9	66.8	64.8
Total Common Shares Outstanding